Hims & Hers Health, INC Form 4 insider transactions

Chief Medical Officer Patrick Harrison Carroll acquired 4,091 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Chief Policy Officer Deborah M. Autor acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Director Christopher D. Payne acquired 14,343 shares of Hims & Hers Health, Inc. through the vesting of Restricted Stock Units.

Director Christiane Pendarvis acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Director Anja Manuel acquired 13,696 shares of Hims & Hers Health, Inc. through the vesting and conversion of restricted stock units.

Director Delos M. Cosgrove acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Director David B. Wells reported a purchase of 48,400 shares of Hims & Hers Health, Inc. Class A Common Stock on May 26, 2026.

Chief Medical Officer Patrick Harrison Carroll received 435 restricted stock units in lieu of cash director fees.

Director Christopher D. Payne was granted 647 restricted stock units in lieu of cash compensation for Q1 2026.

Director David B. Wells received 957 restricted stock units in lieu of cash compensation for Q1 2026 director fees.

Chief Financial Officer Oluyemi Okupe exercised 7,950 stock options and sold the resulting shares under a pre-established Rule 10b5-1 trading plan.

Chief Legal Officer Soleil Boughton sold 9,463 shares of Hims & Hers Health, Inc. stock via a 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe exercised stock options and sold shares under a pre-established Rule 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe sold shares of Hims & Hers Health, Inc. under a pre-established Rule 10b5-1 trading plan.

Andrew Dudum, CEO of Hims & Hers Health, Inc., reported a transfer of 422,933 shares of Class A Common Stock to the Dudum Family Community Property Trust on April 9, 2026.

Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, executed a stock option exercise and subsequent sale of shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health, Inc. CFO Oluyemi Okupe executed a pre-planned stock option exercise and subsequent sale of Class A Common Stock.

Irene Becklund, Principal Accounting Officer of Hims & Hers Health, Inc., sold 5,529 shares of Class A Common Stock for $24.69 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 4,812 shares of Class A Common Stock for $24.69 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi sold 97,289 shares of Class A Common Stock for $24.69 per share pursuant to a pre-arranged trading plan.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting and settlement of Restricted Stock Units and associated tax withholdings.

Hims & Hers Health, Inc. Director Christiane Pendarvis acquired 15,211 shares of Class A Common Stock through the vesting of Restricted Stock Units.

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported the vesting of 16,522 restricted stock units and the withholding of 4,022 shares for tax obligations.

A Hims & Hers Health, Inc. Chief Policy Officer and Director acquired shares through RSU vesting and sold a portion to cover tax obligations.

Irene Becklund, Principal Accounting Officer of Hims & Hers Health, Inc., reported the vesting of Restricted Stock Units and subsequent tax-related share disposals.

Hims & Hers Health, Inc. CEO Andrew Dudum reported the vesting and settlement of restricted stock units and associated tax withholdings of Class A Common Stock.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the vesting and tax-related disposition of Class A Common Stock and Restricted Stock Units.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported routine equity transactions, including RSU vesting and shares withheld for tax obligations.

Hims & Hers Health, Inc. disclosed a grant of 62,076 Restricted Stock Units to Principal Accounting Officer Irene Becklund, vesting over four years.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi was granted 376,222 Restricted Stock Units, vesting over four years.